Christian Elling
Senior Vice President, Managing Partner ΒιΆΉΤΌΕΔ BioCapital
ΒιΆΉΤΌΕΔ BioCapital
Christian E. Elling heads the early stage biotech investment unit ΒιΆΉΤΌΕΔ BioCapital.
Christian E. Elling joined the Lundbeck Foundation in 2012 and heads the early-stage biotech investment unit ΒιΆΉΤΌΕΔ BioCapital. He received his M.Sc. in Biochemistry and his Ph.D. in Pharmacology from the University of Copenhagen, Denmark. Christian was previously co-founder, Vice President of Biology and Development, and later CEO of 7TM Pharma.
Member of the board of directors: Cytoki, IO Biotech, NMD Pharma, SNIPR Biome
Former member of the board of directors: AFYX Therapeutics, EpiTherapeutics, Inagen
